We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).
Hohaus, S., Di Febo, A., Storti, S., Teofili, L., Voso, M. T., Leone, G., Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma., <<HAEMATOLOGICA>>, 2004; 89 (6): 751-752 [http://hdl.handle.net/10807/6337]
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
Hohaus, Stefan;Di Febo, Annalaura;Storti, Sergio;Teofili, Luciana;Voso, Maria Teresa;Leone, Giuseppe
2004
Abstract
We report treatment results obtained with a modified Stanford V regimen in 32 patients with advanced Hodgkin's lymphoma (stage II bulky disease, III, IV). Treatment results were not superior to those achieved with conventional treatment (ABVD) in terms of complete remission and survival rates (progression-free survival and overall survival at 3 years: 66% and 91%, respectively).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
